Thus, the optimal treatment protocol (assuming glucose consumption is minimized) is to pick a safe target fasting glucose which avoids the risk of hypoglycemia, and then titrate the insulin dose to achieve this target glucose. This evidence concerns the gene INS and Hypoglycemia.